AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics, a leading developer of miRNA replacement therapies, presented preclinical data for one of its lead microRNA therapeutic candidates at the Keystone Symposium on MicroRNA and Cancer held June 10 – 15, 2009 in Keystone, Colorado.
